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OBJECTIVES This study examines the prevalence and hemodynamic determinants of mental stress-induced
coronary vasoconstriction in patients undergoing diagnostic coronary angiography.
BACKGROUND Decreased myocardial supply is involved in myocardial ischemia triggered by mental stress,
but the determinants of stress-induced coronary constriction and flow velocity responses are
not well understood.
METHODS Coronary vasomotion was assessed in 76 patients (average age 59.9 6 10.4 years; eight
women). Coronary flow velocity responses were assessed in 20 of the 76 patients using
intracoronary Doppler flow. Repeated angiograms were obtained after a baseline control
period, a 3-min mental arithmetic task and administration of 200 mg intracoronary
nitroglycerin. Arterial blood pressure (BP) and heart rate assessments were made throughout
the procedure.
RESULTS Mental stress resulted in significant BP and heart rate increases (p , 0.001). Coronary
constriction (.0.15 mm) was observed in 11 of 59 patients with coronary artery disease
(CAD) (18.6%). Higher mental stress pressor responses were associated with more constric-
tion in diseased segments (rDSBP 5 20.26, rDDBP 5 20.30, rDMAP 5 20.29; p’s , 0.05)
but not with responses in nonstenotic segments. The overall constriction of diseased segments
was not significant (p . 0.10), whereas a small but significant constriction occurred in
nonstenotic segments (p 5 0.04). Coronary flow velocity increased in patients without CAD
(32.2%; p 5 0.008), but not in patients with CAD (6.4%; p 5 ns). Cardiovascular risk factors
were not predictive of stress-induced vasomotion in patients with CAD.
CONCLUSIONS Coronary vasoconstriction in angiographically diseased arteries varies with hemodynamic
responses to mental arousal. Coronary flow responses are attenuated in CAD patients. Thus,
combined increases in cardiac demand and concomitant reduced myocardial blood supply may
contribute to myocardial ischemia with mental stress. (J Am Coll Cardiol 2001;37:1359–66)
© 2001 by the American College of Cardiology
Mental stress can trigger transient myocardial ischemia in
30% to 60% of patients with coronary artery disease (CAD)
(1,2). Mental stress-induced ischemia in the laboratory is
predictive of ischemia during ambulatory monitoring (3,4)
and of future adverse cardiovascular events (5–7). The
pathophysiologic mechanisms of mental stress-included isch-
emia include activation of the sympathetic nervous system,
resulting in hemodynamic changes leading to increased
cardiac demand (2). However, because the cardiac demand
at which mental stress-induced ischemia occurs is substan-
tially lower than with exercise-induced ischemia (4,8),
impaired supply due to coronary constriction (9–11) or
impaired responses of the myocardial microcirculation (12)
may play important roles in myocardial ischemia elicited by
emotional distress.
Prior studies indicate that paradoxical coronary constric-
tion to mental stress is correlated with constrictive responses
to intracoronary acetylcholine, suggesting endothelial dys-
function as a pathophysiological mechanism (9). Coronary
constriction to mental stress can also occur in the absence of
clinically significant coronary disease (10), which is consis-
tent with observations that risk factors such as hypercholes-
terolemia are associated with acetylcholine-induced coro-
nary constriction in patients free of angiographically
determined CAD (13,14). There is also an impairment of
the normal increase in microcirculatory coronary flow with
mental stress in CAD patients compared with controls (12).
Although some studies have not found significant vasomo-
tor responses to mental stress (11,15), others have docu-
mented mental stress-induced coronary constriction (9,10)
and even complete transient coronary occlusion to mental
stress (16). Thus, the extent of coronary vasomotion may
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vary substantially between patients, and the predictors of
these variations are not known. This study assesses the
magnitude of potential determinants of coronary vasomotor
and microcirculatory responses to mental stress during
cardiac catheterization. We also assess whether the blood
pressure and heart rate responses to mental stress are related
to stress-induced changes in coronary diameter and flow
velocity (4,17–19).
METHODS
Patients. Seventy-six patients referred for diagnostic coro-
nary angiography were enrolled (average age 59.9 6 10.4
years; eight women; 17 African American, 56 Caucasian,
and three other ethnicity). Inclusion criteria were positive
exercise test for inducible myocardial ischemia (n 5 63;
83%), known history of CAD (n 5 7; 9%) or .80% risk of
coronary disease based on risk factors (n 5 6; 8%) (20).
Exclusion criteria were myocardial infarction within the past
month, angioplasty within the past six months, severe
valvular disease or congestive heart failure, age $80 years,
critical left main stenosis, severe three-vessel disease, tech-
nically inadequate coronary angiogram and ejection fraction
,25%. The study was approved by the Institutional Review
Boards of the participating study sites and all patients gave
informed consent.
Vasoactive medications were discontinued for .5 half-
lives before the study, when clinically safe. Beta-blocking
agents were withheld for .48 h, calcium antagonists and
angiotensin-converting enzyme inhibitors for 24 h, and
long-acting nitrates for 6 h as described previously (8,9,21).
Before catheterization, all patients received diphenhydra-
mine (25 mg) for antiemetic purposes. Preprocedural diaz-
epam was withheld when possible (n 5 51); midazolam was
given (0.5 to 1.0 mg) when necessary to reduce anxiety
during the diagnostic procedure (n 5 4).
Procedure. Patients were tested in the morning after an
overnight fast. The protocol consisted of a control period
(3 min rest), mental stress (2.5 to 3 min), and administra-
tion of 200 mg intracoronary nitroglycerin. The duration of
the stress task was based on research demonstrating that
mental stress-induced ischemia occurs within 2 min follow-
ing task onset (22). Administration of intracoronary nitro-
glycerin was used to assess preserved smooth muscle cell
function.
Coronary angiography. Diagnostic catheterization was
performed following standard procedures by percutaneous
Judkins technique. Angiograms were obtained by injection
of a single 5 to 7 cc bolus of nonionic contrast (Isovue-370,
Squibb Diagnostics, Princeton, New Jersey) using a cinean-
giographic system (Bicor, Siemens-Elema, California). At
diagnostic angiography 59 of 76 patients revealed significant
CAD (.50% lesion). Absence of angiographic CAD was
more common among women (63%) than men (18%) but
was not more prevalent among the six patients without a
positive exercise test.
Angiographic assessments were made at the end of the
control, mental stress and nitroglycerin study phases. The
optimal angiographic view of the study lesion was chosen on
the basis of results of the preceding diagnostic angiography,
and camera and patient position were kept constant (9,23).
Mental stress testing. During the resting period, patients
were encouraged to relax, with lights lowered and ambient
noise reduced. Task instructions were then given using a
tape-recorded standard text (9). Patients subtracted serial
sevens from a four-digit number as quickly and accurately as
possible and were frequently interrupted. A metronome was
played loudly as an additional distractor. Patients rated
negative emotions on seven-point Likert scales (anger,
frustration, irritation and anxiety) and two control items
(interest and tiredness) at the end of the control period and
immediately following the mental stress angiogram (total
negative emotion score range 1 to 28). Continuous electro-
cardiograms were recorded and aortic blood pressures were
obtained from the catheter tip (Midas system 2000, E for M
Corporation, Lenexa, Kansas). Average baseline diastolic
blood pressure (DBP), systolic blood pressure (SBP) and
heart rate (HR) during the last 2 min of the resting period
were compared with the average levels during mental stress.
Mean arterial pressure (MAP) was calculated as MAP 5
[(2 3 DBP 1 SBP)/3] and rate pressure product as SBP 3
HR.
Risk factors and clinical characteristics. Risk factors in-
cluded age, gender, body mass index, hypertension, insulin-
dependent diabetes mellitus, current smoking status and
lipid profile. Lipid levels were assessed from samples ob-
tained at the time of catheterization. Total cholesterol and
triglycerides were assessed by an end point method using a
commercially available reagent system and analyzer (Boeh-
ringer Mannheim Corporation, Indianapolis, Indiana).
High density lipoprotein was determined following precip-
itation and centrifugation of low density lipoprotein (LDL)
and very low density lipoprotein. Fractionation was per-
formed with magnesium/phosphotungstate according to a
modification of the Burnstein and Samaille method and
LDL was calculated using the Friedwald equation.
Quantitative coronary angiographic analyses. Quantita-
tive coronary angiography (QCA) was performed at the
Washington Hospital Center Angiographic Core Labora-
tory. Technicians and readers were blinded to patient
characteristics and study phase. Two coronary segments per
Abbreviations and Acronyms
APV 5 average peak velocity
CAD 5 coronary artery disease
DBP 5 diastolic blood pressure
DSVR 5 diastolic systolic velocity ratio
HR 5 heart rate
LDL 5 low density lipoprotein
QCA 5 quantitative coronary angiography
SBP 5 systolic blood pressure
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patient were analyzed; the most likely culprit lesion and a
nonstenotic control segment. Angiographic frames in the
single, most severe, sharpest and unforeshortened projection
were selected for assessment. Nonstenotic control segments
were obtained from a different artery (left anterior descend-
ing and circumflex lesions) or the same artery at the most
proximal location possible (right coronary artery lesions).
Absolute measurements (in mm) of the reference and
minimal luminal diameters (MLD), and mean diameter of
the entire segment were obtained using a previously vali-
dated edge-detection algorithm (CMS, MEDIS, Tilburg,
The Netherlands) as described elsewhere (24,25) (calibra-
tion factors ranged from 0.08 mm to 0.10 mm per pixel).
Percent stenosis was calculated on the basis of the reference
diameter, and plaque area was used as a second indicator of
lesion severity. Because MLD and mean obstruction mea-
sures revealed essentially the same results (r 5 0.87, p ,
0.001) and the latter measure appeared less vulnerable to
artifact, results for mean diameter of obstruction will be
presented here.
Target lesions in the 59 CAD patients revealed a .50%
stenosis by QCA in 44 patients and a 25% to 50%
narrowing in 15 patients. The 15 patients with intermediate
target lesions had more severe distal lesions (.50%) in the
same artery not suitable for QCA (n 5 2), lesions (.50%)
in a different coronary artery (n 5 8), or discrepancy
between visual inspection and offline QCA (n 5 5). In total,
71 diseased and 73 nonstenotic control segments were
analyzed.
Diameter variability estimates using the CMS system
range from 0.09 mm to 0.16 mm (26). To assess reliability
of the present data, 60 images (30 diseased and 30 control
segments) of 10 study patients were analyzed twice with a
blinded procedure and revealed high test-retest correlations
of the diseased (r 5 0.90) and normal (r 5 0.93) segment
diameters. The error range was estimated as 0.15 mm (27),
and coronary constriction was therefore defined as a diam-
eter reduction of 0.15 mm or more, a nonresponse as a
diameter change between 20.15 and 10.15 mm, and
dilation as an increase .0.15 mm.
Doppler flow assessment of coronary flow velocity. A
Doppler flow wire (Cardiometrics Inc., Mountain View,
California) was placed in 21 patients after an additional dose
of 3,000 to 5,000 U of heparin (28). The wire tip was placed
0.5 mm distal to the lesion (n 5 14) or, if no disease was
present (n 5 6), in the proximal left descending coronary
artery (loss of signal occurred in one of 21 patients). Before
angiograms were obtained, the flow wire was temporarily
pulled back to a proximal position in order to allow QCA
without the wire across the lesion. Percent change in
average peak velocity (APV; cm/s) and diastolic systolic
velocity ratio (DSVR) were assessed to measure coronary
flow velocity responses to mental stress (12,28).
Statistical analysis. Angiographic data are presented as
mean 6 standard error and all other data as mean 6
standard deviation or percentages when appropriate. Stress-
induced responses were calculated as change scores and
percentage change from baseline control values. Analyses
for coronary vasomotion were first conducted on a per-
segment basis (71 diseased and 73 nonstenotic segments).
Because responses within patients are not statistically inde-
pendent, further analyses were conducted on a per-patient
basis, examining: 1) diseased segments of CAD patients
(n 5 59); 2) nonstenotic control segments of CAD patients
(n 5 56); and 3) nonstenotic segments of patients without
angiographic CAD (n 5 17). Differences between CAD
patients versus patients without CAD in stress responses
were examined using 2 3 2 mixed-model analysis of
variance. Associations of mental stress-induced hemody-
namic responses with coronary diameter and flow velocity
changes were examined using Pearson correlations. Multiple
regression analyses were used to investigate whether stress-
induced diameter changes were independently predicted by
hemodynamic responses, adjusting for baseline diameter
and CAD risk factors. Two-tailed probabilities and a p level
of ,0.05 were used to indicate statistical significance.
RESULTS
Patient characteristics and task responses. Table 1 shows
patient characteristics; hemodynamic responses to mental
stress are shown in Table 2 (p’s , 0.001). The mental stress
task induced a significant increase in negative emotion (p ,
0.001), whereas no increases in the control items occurred
(p . 0.10). Patients who received preprocedural sedation
(n 5 25/76) experienced less negative emotion during the
task than patients without sedation (p 5 0.01), but hemo-
dynamic and coronary diameter responses did not differ
between these two groups. During mental stress, six patients
experienced anginal chest pain and two other patients
showed .1 mm downsloping ST-segment depression.
Epicardial coronary vasomotion. Coronary responses to
mental stress ranged from 215% constriction to 27%
dilation in diseased segments. Control segments showed a
Table 1. Patient Characteristics
Patients
% of
Patients
Vessel disease
0 17 22
1 24 32
2 21 28
3 14 18
Angina class (NYHA)
Asymptomatic 4 5
I/II 44 58
III/IV 28 37
Previous MI 22 29
History of hypertension 50 66
Hypercholesterolemia 41 54
Lipid lowering medication 19 25
Insulin-dependent diabetes mellitus 11 14
Obesity (body mass index .32 kg/m2) 11 14
Current smoker 28 37
NYHA 5 New Heart Association; MI 5 myocardial infarction.
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similar response range (222% to 12%). No overall constric-
tion was noted in the 71 diseased segments in patients with
CAD (20.4% change; from 2.32 6 0.07 mm to 2.31 6
0.07 mm; p . 0.10), whereas a small but significant
diameter decrease was observed in the 73 nonstenotic
segments (21.4% change; from 2.91 6 0.08 mm to 2.87 6
0.08 mm; p 5 0.04). Percent stenosis and plaque area were
unrelated to coronary vasomotion with mental stress (r 5
0.07 and r 5 20.03, respectively, p . 0.10).
Coronary vasomotion responses analyzed on a per-patient
basis (Table 3) were consistent with results obtained using
coronary segments as unit of analysis. A small but statisti-
cally significant constriction to stress was observed in CAD
patients’ nonstenotic segments from 2.92 6 0.10 mm to
2.87 6 0.10 mm; p 5 0.04), where 14 patients (25.5%)
evidenced constriction (.0.15 mm) and four (7.3%) dilation
(.0.15 mm dilation). Diameter responses of diseased seg-
ments were not significant (from 2.31 6 0.08 mm to 2.30 6
0.08 mm; p . 0.10); 11 patients (18.6%) constricted and 12
(23.5%) dilated. This lack of response was observed in
lesions .50% (n 5 44) as well as lesions of 25% to 50%
(n 5 15). No change in diameter occurred in the 17 patients
without angiographic CAD. Nitroglycerin-induced di-
ameter increases were larger in segments from patients
without CAD (D 5 0.33 6 0.07 mm) than in nonstenotic
segments of patients with CAD (D 5 0.16 6 0.03 mm;
p 5 0.04).
Mental stress-induced ST-depression (n 5 2) or anginal
pain (n 5 6) were not related to coronary constriction,
hemodynamic stress responses, or CAD risk factors (p’s .
0.1).
Patients who were tested on antianginal medication (n 5
21) were not different in measures of coronary diameter or
CAD severity from patients titrated off medications (n 5
33) or not taking such agents (n 5 5). Mean arterial
pressure increases were similar in patients in whom medi-
cations were withheld versus patients tested on medications
(from 123.0 6 15.4 to 138.1 6 17.0 mm Hg and from
118.3 6 19.9 to 130.4 6 20.1 mm Hg, respectively;
pinteraction 5 0.31). Similarly, medication withdrawal did not
alter coronary responses to mental stress (lesions p 5 0.95,
control segments p 5 0.71).
Coronary flow velocity response to mental stress. As
shown in Figure 1, the average peak velocity increased
significantly in patients without CAD during mental stress
(32.8%, p 5 0.008) but not in patients with angiographic
Table 3. Coronary Diameter Change During Mental Stress and Intracoronary Nitroglycerin in
Patients With and Without Angiographic CAD
Patients
Constriction
n (%)
Patients
Dilating
n (%)
Average Diameter Response
(mm)
Baseline
Mean 6 S.E.
Stress
Mean 6 S.E.
Mental Stress
Patients with CAD
Normal segments (n 5 56) 14 (25.5%) 4 (7.3%) 2.92 6 0.10 2.87 6 0.10*
Diseased segments (n 5 59)‡ 11 (18.6%) 12 (20.3%) 2.31 6 0.08 2.30 6 0.08
Patients without angiographic
CAD (n 5 17)
Normal segments 4 (23.5%) 1 (5.9%) 2.87 6 0.13 2.84 6 0.12
Nitroglycerin
Patients with CAD (n 5 59)
Normal segments 3 (5.7%) 25 (47.2%) 2.92 6 0.10 3.09 6 0.10†
Diseased segments 5 (8.8%) 26 (45.6%) 2.30 6 0.08 2.44 6 0.08†
Patients without angiographic
CAD (n 5 17)
Normal segments 1 (6.7%) 11 (73.3%) 2.86 6 0.15 3.19 6 0.17†
*p , 0.05; †p , 0.01; ‡If multiple lesions were present in one patient, the most proximal culprit lesion was selected for the per
patient analyses.
CAD 5 coronary artery disease; S.E. 5 standard error.
Table 2. Hemodynamic and Emotional Measures at Baseline
and During Mental Stress
CAD No CAD
Mean SD Mean SD
Baseline Measures
SBP (mm Hg) 143.9 23.5 135.9 23.5
DBP (mm Hg) 74.0 12.9 74.3 10.5
MAP (mm Hg) 120.6 17.7 115.4 17.7
HR (beats/min) 70.1 12.0 71.8 12.9
RPP (bpm 3 mm Hg
3 103)
10.05 2.18 9.7 2.4
Negative emotion 8.8 4.4 8.8 5.2
Response
SBP (mm Hg) 16.1 13.2* 10.1 13.6*
DBP (mm Hg) 9.6 8.0* 8.3 7.7*
MAP (mm Hg) 13.9 10.8* 9.5 10.9*
HR (beats/min) 7.5 6.9* 11.1 8.8*
RPP (beats/min 3 mm Hg
3 103)
2.3 1.7* 2.4 2.2*
Negative emotion 6.9 6.4* 10.2 5.6*†
*p , 0.001, significant increase from baseline to mental stress. †p , 0.05, differences
in magnitude of response between patients with CAD and patients without CAD.
CAD 5 coronary artery disease; DBP 5 diastolic blood pressure; HR 5 heart
rate; MAP 5 mean arterial pressure; RPP 5 rate pressure product; SBP 5 systolic
blood pressure; SD 5 standard deviation.
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CAD (6.4%; p 5 .0.10; pinteraction 5 0.006). Baseline APV
did not differ between patients with CAD (29.7 6
17.9 cm/s) and without CAD (30.4 6 17.5 cm/s; p 5
.0.10). Similar trends were found for the DSVR (baseline
CAD 1.6 6 0.5, non-CAD 2.0 6 1.3; mental stress CAD
1.5 6 0.5, non-CAD 2.3 6 1.5; pinteraction 5 0.06).
Coronary flow velocity changes during mental stress were
significantly related to diameter responses in nonstenotic
segments (n 5 20, rAPV 5 0.51, p 5 0.03; rDSVR 5 0.46,
p 5 0.05). Associations between APV change and diameter
increase in control segments of patients with CAD (rAPV 5
0.52) were comparable to non-CAD (rAPV 5 0.49) patients.
In contrast, flow velocity measures were not correlated with
the percent diameter change of diseased segments.
Hemodynamic responses and coronary vasoconstriction.
Diameter changes in diseased arteries were inversely asso-
ciated with mental stress-induced changes in SBP (r 5
20.26; p 5 0.05), DBP (r 5 20.30; p 5 0.02), MAP (r 5
20.29; p 5 0.03), and rate pressure product (r 5 20.27;
p 5 0.04). Heart rate responses were not significantly
related to vasomotion (r 5 20.14; p 5 .0.10). Diastolic
reactivity and coronary vasomotion were correlated in dis-
eased segments, but not in nonstenotic segments of CAD
patients (Fig. 2). Similar results were found for severe
(.50%) versus moderate (25% to 50%) lesions. Comparing
high blood pressure responders with low responders, signif-
icantly more constriction (analysis of variance p 5 0.024)
occurred in the high-DBP responders (Fig. 3).
Figure 1. Coronary flow velocity response to mental stress in patients with coronary artery disease (CAD) compared with patients free of angiographic
CAD. Average peak velocity (vertical axis) increased significantly during mental stress in patients without CAD (32.8%, p 5 0.008), whereas no such
increase occurred in patients with CAD (6.4%; p 5 .0.10; pgroup 3 response interaction 5 0.006). No group differences (CAD vs. non-CAD) were found in
pretask resting velocity measures (29.7 6 17.9 cm/s vs. 30.4 6 17.5 cm/s, respectively, p . 0.10).
Figure 2. Associations between diastolic blood pressure reactivity to mental stress and coronary vasomotion in diseased and nonstenotic segments of patients
with coronary artery disease. An inverse relationship was found between diastolic blood pressure responses and coronary diameter changes in diseased
segments (rDDBP 5 20.30, p 5 0.02), whereas no relationship was found between blood pressure responses and coronary constriction in nonstenotic
arteries (rDDBP 5 20.02, p . 0.10). This finding was confirmed by multivariate regression analysis.
1363JACC Vol. 37, No. 5, 2001 Kop et al.
April 2001:1359–66 Mental Stress and Coronary Vasomotion
Cardiovascular risk factors and clinical status. No asso-
ciations were observed between coronary diameter changes
and risk factors. In patients free of angiographic CAD,
triglyceride levels were associated with constriction; r 5
20.64; p 5 0.02. Indicators of clinical status (number of
diseased vessels, ejection fraction, anginal class, peripheral
vascular disease, exercise tolerance and maximum heart rate
during exercise) were not related to coronary vasomotion.
Multivariate analyses showed that stress-induced DBP
responses were significantly associated with coronary vaso-
motion (b 5 20.28; p 5 0.05), after statistically correcting
for risk factors and the lesion severity (Table 4). Systolic
blood pressure and MAP responses showed similar trends
(b 5 20.22, p 5 0.11; b 5 20.25, p 5 0.076, respectively).
DISCUSSION
This study demonstrates that epicardial coronary vasocon-
striction in response to mental stress is related to stress-
induced blood pressure increases. Coronary flow velocity
responses during mental stress were impaired in patients
with angiographic CAD. These findings suggest that men-
tal stress-induced myocardial ischemia is produced by both
increased cardiac demand and a concomitant decrease in
coronary supply.
Stress-induced paradoxical vasoconstriction in coronary
artery disease. Prior research on mental stress-induced
coronary vasomotion has revealed mixed results. Yeung et
al. (9) documented that mental stress resulted in a 24%
diameter constriction in diseased arteries, 9% constriction in
irregular segments, and 13% dilation of normal segments.
One other small study also reported significant mental
stress-induced coronary constriction (10), and we have
reported one case of complete coronary occlusion with
mental stress (16). However, in the present study, only
18.6% of CAD patients displayed mental stress-induced
coronary constriction, and two other studies did not find
significant vasomotor responses to mental stress (11,15).
The discrepancy between our observations and those of
Yeung et al. (9) cannot be explained by differences in
duration of the mental challenge task, statistical power,
lesion severity or the extent of hemodynamic responses.
Potential factors accounting for differences between these
mental challenge studies include the QCA techniques,
adequacy of blinding and patient characteristics. It is also
possible that coronary calcification accounts for the absence
of a vasoconstrictive response in the diseased segments in
our study.
The observed association of hemodynamic responses to
mental stress with constriction in diseased, but not nonste-
notic, epicardial arteries is consistent with studies of coro-
nary responses to increased cardiac demand by exercise (29),
cold pressor (30,31) and pacing (32). The present study
extends these findings in quantifying changes in vasomotion
and flow velocity to mental stress.
Mechanisms of coronary vasomotion. Attenuation of
flow-mediated vasodilation via release of endothelial nitric
oxide in the presence of endothelial damage (31,33) may be
one mechanism explaining the relationship between pressor
responses and decreases in coronary diameter with mental
stress. Furthermore, the small but statistically significant
constriction in nonstenotic segments is consistent with
reports of acetylcholine-induced constriction and endothe-
lial dysfunction in angiographically normal segments (34).
Other evidence suggests that acetylcholine induces epicar-
dial constriction only in segments with very minor athero-
sclerosis (35).
Coronary flow velocity increased in patients without
CAD, whereas no flow velocity response was observed in
CAD patients. These findings support the suggestion (12)
that vasomotion of diseased epicardial segments may not
play a large role in impaired coronary flow response to
mental stress.
Study limitations. This study assessed a larger sample of
patients with mental stress testing than any of the existing
studies, but many of the coronary diameter responses were
in the error range (60.15 mm) of QCA analyses. Subtle
changes in epicardial diameter may have remained unde-
tected by the angiographic assessment techniques used in
this study. However, minimal diameter changes are not
likely to result in physiologically important decreases in
Table 4. Multivariate Analyses Predicting Mental Stress-
Induced Coronary Diameter Response From Diastolic Blood
Pressure Increases and Control Variables
Variable B SD B b p
DBP response 20.27 0.13 20.28 0.05
Coronary diameter 22.97 1.75 20.23 0.09
Gender 4.57 4.62 0.13 0.33
Age 0.12 .11 0.15 0.26
Body mass index 0.15 .26 0.08 0.57
Diabetes 1.03 2.89 0.05 0.72
Hypercholesterolemia 0.19 1.28 0.02 0.88
Hypertension 21.65 2.45 20.10 0.50
Figure 3. Differential coronary vasomotor response in patients with low,
moderate and high diastolic blood pressure (DBP) responses to mental
stress. High diastolic blood pressure responders (upper tertile) displayed
significantly more coronary constriction compared to low responders
(analysis of variance p 5 0.02).
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coronary flow (15). Another limitation concerns the short
duration of the pretask rest and the mental challenge task.
However, significant hemodynamic and emotional re-
sponses were elicited, comparable to other studies in this
area. Finally, as a result of assessing catheterization patients,
stress-induced ischemia was assessed using ST segment
analysis only. ST segment depression and angina are in-
sensitive indicators of mental stress-induced ischemia
(4,3,8,17–19). Further studies are needed to validate
whether mental stress-induced coronary vasomotion is re-
lated to more sensitive measures of ischemia such as
ventriculography and perfusion studies.
Clinical implications. Mental stress-induced myocardial
ischemia occurs in a substantial number (30% to 60%) of
patients with stable coronary artery disease (2–4,8,22,36–
38) and is predictive of future cardiac events (5–7). Research
also shows that the magnitude of stress-induced hemody-
namic responses is related to the occurrence of ischemia
during laboratory mental stress testing (4,17,18). The
present study shows that hemodynamic responses to mental
arousal are associated with coronary constriction, and that
this association is not related to risk factors such as hyper-
lipidemia and hypertension. Thus, a combined increase in
cardiac demand and a parallel impaired increase in myocar-
dial supply may summate in mental stress-induced ischemia.
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